Table 2.
GDS (continuous) | GDS (binary) | |||||
---|---|---|---|---|---|---|
|
|
|||||
Estimate | z value | Pr(>|z|) | Estimate | z value | Pr(>|z|) | |
(Intercept) | 1.49 | 10.504 | < 2×10−16 | 2.84 | 4.261 | 2.03×10−5 |
Age | 6.15×10−4 | 0.358 | 0.7201 | −4.04×10−3 | −0.474 | 0.6356 |
Nadir CD4 | −1.65×10−4 | −1.894 | 0.0585 | −3.63×10−4 | −0.833 | 0.4049 |
Plasma VL | 7.56×10−3 | 0.528 | 0.5975 | 6.07×10−2 | 0.865 | 0.3869 |
ART usea | −7.52×10−2 | −1.636 | 0.1021 | −0.585 | −2.532 | 0.0114 |
WRAT | −6.80×10−3 | −6.361 | 3.01×10−10 | −3.04×10−2 | −5.728 | 1.02×10−8 |
PC1 | −4.15 | −7.967 | 4.28×10−15 | −15.8 | −5.913 | 3.35×10−9 |
PC2 | 0.298 | 0.627 | 0.5306 | 2.02 | 0.913 | 0.3614 |
comorbidityb | −0.188 | −6.24 | 6.38×10−10 | −0.692 | −4.85 | 1.23×10−6 |
categorical parameters (i.e., “on” versus “off” ART).
categorized as “minimal” or “not contributing” to NCI versus “contributing” to NCI.
Abbreviations: nadir CD4, nadir CD4+ T-cell count; plasma VL, log10(plasma HIV RNA copies/mL); ART use, on vs. off antiretroviral therapy at the time of neurocognitive assessment; WRAT, wide-range achievement test (estimate of reading comprehension and IQ); PC, principal component.